BIRC5 and hepatocellular carcinoma: Therefore, in order to explore, confirm, and evaluate the diagnostic significance of anti-BIRC5 autoantibody in patients with ANHCC as well as in whole HCC patients, a total of 744 individuals were enrolled for this study and categorized into the discovery, validation and evaluation stages.